Misoprostol for preoperative cervical ripening in hysteroscopy: a randomised controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15005976

Enrollment

Unknown

Registered

2015-02-11

Start date

2015-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterus cavity

Interventions

misoprostol vaginally 600ug:misoprostol vaginally 600ug

misoprostol orally 600ug:misoprostol orally 600ug

misoprostol vaginally 200ug:misoprostol vaginally 200ug

misoprostol orally 200ug:misoprostol orally 200ug

vitamin B6 vaginally :vitamin B6 vaginally

vitamin B6 orally :vitamin B6 orally

Eligibility

Sex/Gender

Female

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patiens aged 20-70 requiring hysteroscopy operation for various reasons.

Exclusion criteria

Exclusion criteria: All prostaglandin taboo patients; pregnancy; reproductive tract infection; combined major organ diseases.

Design outcomes

Primary

Measure	Time frame
cervical width;time to dilatation;	—

Secondary

Measure	Time frame
procedure time;difficulty for dilatation;	—

Contacts

Public ContactZhuo Zihong

zhuozhihong1@163.com+86 13586547486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026